First human demonstration of cardiac stimulation with transcutaneous ultrasound energy delivery - Implications for wireless pacing with Implantable devices

被引:60
作者
Lee, Kathy L.
Lau, Chu-Pak
Tse, Hung-Fat
Echt, Debra S.
Heaven, David
Smith, Warren
Hood, Margaret
机构
[1] Queen Mary Hosp, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China
[2] EBR Syst Inc, Sunnyvale, CA USA
[3] Auckland City Hosp, Greenlane Cardiovasc Serv, Div Cardiol, Auckland, New Zealand
关键词
D O I
10.1016/j.jacc.2007.04.081
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The purpose of this study was to evaluate the feasibility and safety of a novel technology that uses energy transfer from an ultrasound transmitter to achieve cardiac stimulation without the use of a pacing lead in humans. Background To overcome the limitations of pacemaker leads, a new technology enabling stimulation without the use of a lead is desirable. Methods A steerable bipolar electrophysiology catheter incorporating a receiver electrode into the tip and circuitry to convert ultrasound energy to electrical energy was inserted transvenously into the heart. An ultrasound transmitting transducer was placed on the chest wall with ultrasound gel. Ultrasound energy was amplitude-adjusted and transmitted at 313 to 385 kHz. The output waveform of the receiver electrode was monitored while the transmitter was moved on the chest wall to target the receiver. The ultrasound transmission amplitude was limited to a mechanical index of 1.9, the maximum allowed for ultrasound imaging systems. Ultrasound-mediated pacing with minimum voltage but consistent capture was obtained for 12 s. Results Twenty-four patients (48 +/- 12 years) were tested during or after completion of clinical electrophysiology procedures. A total of 80 pacing sites were tested (mean 3.3 sites/patient): 12 right atrial, 35 right ventricular, and 33 left ventricular (31 endocardial) sites. The transmit-to-receive distance was 11.3 +/- 3.2 cm (range 5.3 to 22.5 cm). Ultrasound-mediated pacing was achieved at all 80 test sites, with consistent capture at 77 sites. The mechanical index during pacing was 0.5 +/- 0.3 (range 0.1 to 1.5). The mean ultrasound-mediated capture threshold was 1.01 +/- 0.64 V. There was no adverse event related to ultrasound pacing. No patient experienced discomfort during pacing. Conclusions The feasibility and safety of pacing usng ultrasound energy has been shown acutely.
引用
收藏
页码:877 / 883
页数:7
相关论文
共 20 条
[1]   Cardiac resynchronization therapy: Current state of the art - Cost versus benefit [J].
Auricchio, A ;
Abraham, WT .
CIRCULATION, 2004, 109 (03) :300-307
[2]   Cardiac resynchronization therapy - Part 2 - Issues during and after device [J].
Bax, JJ ;
Abraham, T ;
Barold, SS ;
Breithardt, OA ;
Fung, JWH ;
Garrigue, S ;
Gorcsan, J ;
Hayes, DL ;
Kass, DA ;
Knuuti, J ;
Leclercq, C ;
Linde, C ;
Mark, DB ;
Monaghan, MJ ;
Nihoyannopoulos, P ;
Schalij, MJ ;
Stellbrink, C ;
Yu, CM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (12) :2168-2182
[3]   Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure [J].
Bristow, MR ;
Saxon, LA ;
Boehmer, J ;
Krueger, S ;
Kass, DA ;
De Marco, T ;
Carson, P ;
DiCarlo, L ;
DeMets, D ;
White, BG ;
DeVries, DW ;
Feldman, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2140-2150
[4]   The effect of cardiac resynchronization on morbidity and mortality in heart failure [J].
Cleland, JGF ;
Daubert, J ;
Erdmann, E ;
Freemantle, N ;
Gras, D ;
Kappenberger, L ;
Tavazzi, L ;
Cleland, JGF ;
Daubert, JC ;
Erdmann, E ;
Gras, D ;
Kappenberger, L ;
Klein, W ;
Tavazzi, L ;
Poole-Wilson, PA ;
Rydén, L ;
Wedel, H ;
Wellens, HJJ ;
Uretsky, B ;
Thygesen, K ;
Böcker, D ;
Marijianowski, MMH ;
Freemantle, N ;
Calvert, MJ ;
Christ, G ;
Fruhwald, F ;
Hofmann, R ;
Krypta, A ;
Leisch, F ;
Pacher, R ;
Rauscha, F ;
Tavernier, R ;
Thomsen, PEB ;
Boesgaard, S ;
Eiskjær, H ;
Esperen, GT ;
Haarbo, J ;
Hagemann, A ;
Korup, E ;
Moller, M ;
Mortensen, P ;
Sogaard, P ;
Vesterlund, T ;
Huikuri, H ;
Niemelä, KI ;
Toivonen, L ;
Bauer, F ;
Cohen-Solal, A ;
Crocq, C ;
Djiane, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (15) :1539-1549
[5]   Feasibility and safety of a novel technology for pacing without leads [J].
Echt, Debra S. ;
Cowan, Mark W. ;
Riley, Richard E. ;
Brisken, Axel F. .
HEART RHYTHM, 2006, 3 (10) :1202-1206
[6]  
FDA, 1997, INF MAN SEEK MARK CL
[7]   Pacemaker and defibrillator lead extraction [J].
Kutalek, SP .
CURRENT OPINION IN CARDIOLOGY, 2004, 19 (01) :19-22
[8]   Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing [J].
Lamas, GA ;
Orav, J ;
Stambler, BS ;
Ellenbogen, KA ;
Sgarbossa, EB ;
Huang, SKS ;
Marinchak, RA ;
Estes, NAM ;
Mitchell, GF ;
Lieberman, EH ;
Mangione, CM ;
Goldman, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (16) :1097-1104
[9]   Selective site pacing: Defining and reaching the selected site [J].
Lieberman, R ;
Grenz, D ;
Mond, HG ;
Gammage, MD .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2004, 27 (06) :883-886
[10]   Systematic review: Cardiac resynchronization in patients with symptomatic heart failure [J].
McAlister, FA ;
Ezekowitz, JA ;
Wiebe, N ;
Rowe, B ;
Spooner, C ;
Crumley, E ;
Hartling, L ;
Klassen, T ;
Abraham, W .
ANNALS OF INTERNAL MEDICINE, 2004, 141 (05) :381-390